With this approach, the benefits of recombinant human growth hormone therapy can be substantial and the risks modest and tolerable.

Growth-hormone (GH) secretion is reduced in obesity, but studies of GH therapy in obese individuals have produced conflicting results. A meta-analysis of studies on the effects of recombinant ...

Today, the older sister stands 154 cm, while the younger twin is 155 cm — both are still below the median height of 156.3 cm ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...

Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources ...

OPKO Health’s weekly growth hormone injection could be approvable in adults without need for further clinical trials, the company has told pharmaphorum. The biotech has worked with Pfizer to co ...

Ascendis Pharma (ASND) said the FDA has accepted for its supplemental Biologics License Application for TransCon hGH for the treatment of adult growth hormone deficiency, or GHD. The agency has set a ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Although the mechanism of hypothyroidism after growth hormone replacement therapy remains unclear, this therapy has been reported to increase peripheral deiodination of T 4 to T 3 and secretion of ...

Growth hormone deficiency that starts during childhood ... to form a solution that you give yourself as a subcutaneous injection. It’s available as a cartridge that’s attached to a reusable ...